Patents Assigned to MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY
-
Publication number: 20250019696Abstract: A use of ganoderma fungal RNA molecules, a drug, a drug composition and a delivery carrier are provided. It has been proved that the tRFs derived from the ganoderma traditional Chinese medicine has an obvious inhibiting effect on airway smooth muscle cell phenotype change (proliferation, abnormal secretion and the like) induced by TGF-?1 and AHR, inflammation and remodeling of asthma mice induced by Dermatophagoides pteronyssinus in the experiments of the present disclosure, which suggests that the tRFs derived from the ganoderma traditional Chinese medicine and a pharmaceutical composition can be a brand new medicine for treating asthma. The drug comprises the RNA molecule and a pharmaceutically acceptable carrier, diluent and/or excipient. The present disclosure is helpful for the research and development of asthma treatment drugs and provides reference for the research and development of other respiratory system disease treatment drugs.Type: ApplicationFiled: November 17, 2022Publication date: January 16, 2025Applicant: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Zhihong JIANG, Yuan MA, Fei REN
-
Patent number: 10900966Abstract: The present invention discloses a method of determining the presence of autoimmune disease with the use of glycan biomarkers. A method of improving the detection sensitivity of trace glycans from a mixture of glycans and a microfluidic chip therefor are also disclosed.Type: GrantFiled: February 21, 2019Date of Patent: January 26, 2021Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Liang Liu, Jing-Rong Wang, Weina Gao, Leefong Yau, Hao Huang, Qiong Meng, Tiantian Tong, Zhi-Hong Jiang
-
Patent number: 10702500Abstract: One embodiment is a method of treating cancer. The method includes administering a therapeutically effective amount of a compound to a patient.Type: GrantFiled: January 24, 2019Date of Patent: July 7, 2020Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Xiao Jun Yao, Lai Han Elaine Leung, Liang Liu, Qian Qian Wang, Jia Hui Xu, Ying Li
-
Patent number: 10688105Abstract: A method for treating a subject suffering from refractory rheumatoid arthritis includes the step of administering an effective amount of a quinonemethide triterpenoid or a pharmaceutically tolerable salt, solvate or anhydrate thereof to the subject. Also is a method for inducing autophagy in a synovial fibroblast, and a method of inducing calcium mobilization in a synovial fibroblast. Further a pharmaceutical composition includes an effective dose of a quinonemethide triterpenoid and an anti-arthritis compound. The quinonemethide triterpenoid is suitable to treat refractory rheumatoid arthritis (RA) in particular ABC-protein-dependent RA and apoptosis-deficient RA. The quinonemethide triterpenoid also possesses significant inhibitory effects on the growth of synovial fibroblasts, in particular modulating the calcium homeostasis in multidrug-resistant rheumatoid arthritis synovial fibroblasts.Type: GrantFiled: July 10, 2017Date of Patent: June 23, 2020Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Liang Liu, Kam Wai Wong, Yuen Kwan Law, Cong Ling Qiu
-
Patent number: 10658936Abstract: Controlling operation of a converter circuit regulating power transfer between first and second voltage sources includes comparing a detected power value in the converter circuit with a power command value; determining a converter gain based on detected first and second voltage levels of the first and second voltage sources; and determining operation signals for transmitting to switches in the converter circuit during a steady state to control switching time and duration. When the detected power value differs from the power command value, the method includes determining values of two or more variables associated with adjustment of switching time and duration based on the detected first and second voltage levels; and determining operation signals to transmit to the switches during a power transition state based on the determined values of the two or more variables to adjust switching time and switching duration of the switches, thereby regulating power transition.Type: GrantFiled: May 5, 2017Date of Patent: May 19, 2020Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Chuan Sun, Xiao Dong Li
-
Patent number: 10643873Abstract: A system and method of controlling a cluster tool apparatus, wherein the cluster tool includes one or more processing modules and a robot that is configured to move a semiconductor product to and from the one or more processing modules, the cluster tool configured for processing semiconductor products. The method of controlling the cluster tool apparatus to perform a processing cycle includes receiving a plurality of system parameters from a user interface, wherein the system parameters relate to one or more processing steps of the processing cycle, determining a schedule for performing the processing cycle utilizing the one or more processing modules, wherein the schedule being determined based on a semiconductor product residency parameter.Type: GrantFiled: September 13, 2016Date of Patent: May 5, 2020Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Naiqi Wu, Fajun Yang, Yan Qiao, Mengchu Zhou, Zhiwu Li
-
Patent number: 10635786Abstract: A method improves information security by generating a key with which a first multimedia content is encrypted into a second multimedia content. The method generates a first representation for the first multimedia content and a second representation for the second multimedia content on a complex plane, and improves the information security by generating the key by determining a relationship between the first representation and the second representation on the complex plane such that the first multimedia content is encrypted into the second multimedia content with the relationship as the key.Type: GrantFiled: March 15, 2017Date of Patent: April 28, 2020Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Zhanchuan Cai, Ting Lan
-
Method of isolating anti-viral ingredients from , compositions comprising them and their medical use
Patent number: 10537601Abstract: The present invention provides a method of isolating at least one ingredient with anti-viral efficacy from Baphicacanthus cusia. The ingredient can be an alkaloid, a triterpenoid, a lignan, a phenylethanoid, a sesquiterpene lactone, or a flavonoid. Two new alkaloids are produced, which have not been previously reported. Moreover, the method isolates 12 compounds which could not or have not been previously isolated. A pharmaceutical composition includes the at least one ingredient and at least one pharmaceutical tolerable excipient. A method of treating a subject suffering from a viral disease includes administering at least one ingredient isolated from Baphicacanthus cusia.Type: GrantFiled: April 4, 2016Date of Patent: January 21, 2020Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Jing-Rong Wang, Zhi-Hong Jiang, Qi-Tong Feng, Guo-Yuan Zhu, Wei-Na Gao, Zifeng Yang, Nanshan Zhong -
Patent number: 10520914Abstract: A system and method of controlling a multi cluster tool system configured to process a semiconductor product includes a plurality of cluster tools arranged adjacent each other, a buffer module positioned between a pair of cluster tools, each cluster tool including a plurality of processing modules and a robot, the method of controlling a multi cluster tool system including receiving a plurality of system parameters from a user interface, wherein the system parameters correspond to one or more processing steps in a system cycle, wherein the system cycle is a cycle of processing the semiconductor product, determining a system schedule for defining the system cycle for processing a semiconductor product, the system schedule providing robot waiting times for each robot of each cluster tool, controlling, via a controller, the operation of each robot of each cluster tool based on the determined schedule.Type: GrantFiled: September 19, 2016Date of Patent: December 31, 2019Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Naiqi Wu, Fajun Yang, Liping Bai, Mengchu Zhou, Zhiwu Li
-
Patent number: 10519500Abstract: A method of preparing a crystalline copper-based coordination polymer comprises preparing a mixture of copper ions and a first quaternized carboxylate pyridyl ligand; adding a second polypyridyl ligand; and forming crystals of a copper-based coordination polymer therefrom. The crystalline copper-based coordination polymer is suitable for providing a sensing platform for detecting the presence of one or more target nucleic acid sequences such as viral RNA, in particular Dengue virus and/or Zika virus RNA with high selectivity and high specificity. A method of detecting at least a first target nucleic acid sequence, in particular from a viral RNA, in particular it is Flavivirus RNA, in a sample is also provided. Further provided is a kit including the crystalline copper-based coordination polymer and an oligonucleotide probe.Type: GrantFiled: May 22, 2017Date of Patent: December 31, 2019Assignees: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY, SOUTHERN MEDICAL UNIVERSITYInventors: Jin-Xiang Chen, Bao-Ping Xie, Gui-Hua Qiu, Pei-Pei Hu, Zhen Liang, Ye-Mei Liang, Bin Sun, Li-Ping Bai, Zhi-Hong Jiang
-
Patent number: 10493118Abstract: A method for treating a subject suffering from a neurodegenerative disease includes administering at least one triterpenoid which can be obtained from Hedera helix. A method for treating a subject suffering from a neurodegenerative disease includes administering an effective amount of a Hedera helix extract which comprises the triterpenoid. The neurodegenerative disease is preferably but not exclusively Parkinson's disease or Huntington's disease. Methods for extracting the triterpenoid from Hedera helix and a method for inducing autophagy in cells by contacting them with the triterpenoid are also provided. The triterpenoid allows an exceptional induction of autophagy, in particular a significant reduction of the protein level of mutant huntingtin, a significant reduction of the protein level of A53T ?-synuclein, a significant inhibition of the oligomerization of ?-synuclein and a significant inhibition of the inclusion formation of huntingtin via the AMPK-mTOR dependent autophagy inducing pathway.Type: GrantFiled: September 29, 2016Date of Patent: December 3, 2019Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Yuen Kwan Law, Kam Wai Wong, An Gao Wu, Liang Liu, Zeng Wu
-
Patent number: 10438699Abstract: A system and a method for determining an association of one or more biological features with a medical condition provides empirical results and simulations confirming that the involvement of both L1/2-regularized logistic regression and L2-regularized logistic regression in the regression model is highly competitive against usual approaches like Lasso, L1/2, SCAD-L2, and Elastic net in analyzing high dimensional and low sample sizes data.Type: GrantFiled: May 10, 2016Date of Patent: October 8, 2019Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Yong Liang, Hai-Hui Huang, Xiao-Ying Liu
-
Patent number: 10369127Abstract: A method for inhibiting the expression and/or functional activity of an ABC transporter protein in a subject suffering from a disorder associated with an overexpression of the ABC transporter protein includes administrating a cobalt-polypyridyl complex to the subject. A method for inhibiting the expression and/or functional activity of an ABC transporter in cells includes contacting the cells with an effective amount of the cobalt-polypyridyl complex.Type: GrantFiled: June 26, 2017Date of Patent: August 6, 2019Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Kam Wai Wong, Yuen Kwan Law, Man Chung Wong
-
Patent number: 10342777Abstract: A caffeoylquinic acid-rich extract obtained from Erigeron multiradiatus and a method for producing the same. A caffeoylquinic acid-rich extract includes at least 15% by weight of a mixture of certain caffeoylquinic acids. The extract with the mixture of caffeoylquinic acids is highly efficacious in treating and preventing myocardial ischemia or myocardial ischemia reperfusion injuries. A method for treating or preventing a disease caused by myocardial ischemia or myocardial ischemia reperfusion includes administering a therapeutically effective amount of the caffeoylquinic acid-rich extract to a subject. Pharmaceutical compositions including the caffeoylquinic acid-rich extract are also disclosed.Type: GrantFiled: October 1, 2015Date of Patent: July 9, 2019Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Pei Luo, Zhifeng Zhang, Hao Zhang
-
Patent number: 10322097Abstract: A quinonemethide triterpenoid is administered to subjects with multidrug-resistant cancer, in particular a cancer with enhanced expression and/or functional activity of ABC transporter proteins such as P-glycoprotein and/or an apoptosis-deficient, in particular p53-, Bax- or Bak-deficient, cancer, i.e. specific subgroups of subjects with cancer. The quinonemethide triterpenoid is suitable to treat cancer allowing for an accumulation of cytotoxic or therapeutic compounds in the cells while having exceptionally increased cytotoxic activity towards the multidrug-resistant cancer cells and while allowing for an increased activity of chemotherapeutic compounds. Methods for specifically targeting cancer cells with multidrug-resistance and methods for potentiating the activity of a chemotherapeutic compound in those cancer cells are also disclosed. A kit including a quinonemethide triterpenoid and a chemotherapeutic compound is also provided.Type: GrantFiled: December 16, 2015Date of Patent: June 18, 2019Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Kam Wai Wong, Yuen Kwan Law, Thomas Efferth, Su-Wei Xu, Sami Hamdoun, Liang Liu
-
Patent number: 10260114Abstract: The present invention relates in a first aspect to a method of preparing a crystalline lanthanum-carboxylate coordination polymer and the crystalline lanthanum-carboxylate coordination polymer obtained or obtainable by the method. In another aspect of the present invention, also provides a method of detecting a target nucleic acid sequence in a sample.Type: GrantFiled: May 18, 2017Date of Patent: April 16, 2019Assignees: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY, SOUTHERN MEDICAL UNIVERSITYInventors: Jin-Xiang Chen, Bin Sun, Bao-Ping Xie, Zhi-Hong Jiang, Li-Ping Bai
-
Patent number: 10220064Abstract: Methods of treating a subject suffering from an ischemic condition and of preventing an ischemia-reperfusion injury in a subject suffering from an ischemic condition, particularly, but not exclusively ischemic heart disease and the subject is in particular a human, includes administering an effective amount of a carbohydrate composition extracted from Panax ginseng to the subject. The carbohydrate composition of the present invention extracted from Panax ginseng shows exceptional cardio-protective effect and, thus, provides a highly advantageous and highly promising treatment option for treatment of ischemic conditions and prevention of ischemia-reperfusion injury. The present invention further provides a method of protecting cells against hypoxia and reoxygenation induced cell death. Still further, the present invention provides a carbohydrate composition extracted from Panax ginseng and a pharmaceutical formulation comprising it.Type: GrantFiled: November 8, 2016Date of Patent: March 5, 2019Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Hua Zhou, Quanbing Han, Yihan Zuo, Liang Liu, Ruiqi Yue
-
Patent number: 10192642Abstract: A system and a method for determining an association of at least one biological feature with a medical condition, in particularly, but not exclusively, a system and a method of determining an association of at least one biological feature in form of a gene expression with cancer or a subtype of cancer that can include the generation of a simplified protein-protein interaction network based on processed biological data. The system and respective method is especially suitable for analysis of high dimensional and low sample size biological datasets such as in cancer research.Type: GrantFiled: May 10, 2016Date of Patent: January 29, 2019Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Yong Liang, Hua Chai, Xiao-Ying Liu
-
Patent number: 10134613Abstract: A system and method for a cluster tool apparatus for processing a semiconductor product including processing modules located adjacent each other and configured to process a semiconductor module, loadlocks configured to retain and dispense unprocessed semiconductor products and each positioned adjacent one of the processing modules, a robot configured to load, transfer and unload a semiconductor product to and from the processing modules, a hardware controller in communication with the robot and executing a method to close down the cluster tool apparatus to an idle state, the method including determining a status of the processing modules, determining if a close down process is required based on the status or based on a close down signal, and, if required, determining a schedule for a close down process based on a semiconductor product residency parameter, and controlling the operation of the robot based on the schedule to perform the close down process.Type: GrantFiled: September 22, 2016Date of Patent: November 20, 2018Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Yan Qiao, Mengchu Zhou, Naiqi Wu, Zhiwu Li, Qinghua Zhu
-
Patent number: 10111876Abstract: A compound for treating a disease, in particular cancer like non-small cell lung cancer, exceptionally inhibits activity of oncogenic ALK kinase. Compositions, particularly pharmaceutical compositions, are provided comprising this compound. Methods for targeting cancer cells harboring an abnormality in the ALK gene are also The compound for treating a disease has certain structural elements, namely a tricyclic, more specifically heterocyclic, backbone as the core part of the compound at least one highly electronegative atom in form of a tertiary amine attached to the backbone via an at most 6-membered linking group with a terminal highly electronegative atom in form of a nitrogen as secondary amine, and a further hydrophobic moiety fused to the backbone. The structural components allow for an advantageous interaction with the ALK kinase domain. The compound therefor represents a highly promising treatment option for patients in particular those bearing ALK-dependent non-small cell lung cancer.Type: GrantFiled: August 17, 2016Date of Patent: October 30, 2018Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Xiao-Jun Yao, Elaine Lai-Han Leung, Lian-Xiang Luo, Liang Liu